➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Medtronic
Merck
Mallinckrodt
Express Scripts

Last Updated: September 25, 2020

DrugPatentWatch Database Preview

PRECOSE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Precose, and what generic alternatives are available?

Precose is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in PRECOSE is acarbose. There are six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the acarbose profile page.

US ANDA Litigation and Generic Entry Outlook for Precose

A generic version of PRECOSE was approved as acarbose by HIKMA on May 7th, 2008.

  Start Trial

Paragraph IV (Patent) Challenges for PRECOSE
Tradename Dosage Ingredient NDA Submissiondate
PRECOSE TABLET;ORAL acarbose 020482 2005-03-22

US Patents and Regulatory Information for PRECOSE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-004 May 29, 1997 DISCN Yes No   Start Trial   Start Trial   Start Trial
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-001 Sep 6, 1995 DISCN Yes No   Start Trial   Start Trial   Start Trial
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-002 Sep 6, 1995 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PRECOSE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-004 May 29, 1997   Start Trial   Start Trial
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-002 Sep 6, 1995   Start Trial   Start Trial
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-001 Sep 6, 1995   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Baxter
Merck
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.